Rapid HTAs of six medical devices released in Tuscany in April 2026

The Tuscany Regional Healthcare HTA body issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With the regional decree 7084 of April 2, 2026, Tuscany Regional Healthcare published six rapid HTA reports (four new assessments and two reassessments) on medical devices.

Some examples are provided below:

• Harzati Beauty, an injectable gel based on hyaluronic acid for patients with scleroderma, skin atrophy, HIV-induced lipoatrophy, burns, and scarring (new assessment);
• VersaCross Steerable Access Solution by Boston Scientific, a procedural kit with a radiofrequency guidewire and sheath designed to facilitate transseptal catheterization procedures, for patients with non-standard or anatomically complex atrial septum (thick, floppy, postcardiac surgery, or with a device in the atrial septum) (reassessment).

See the regional decrees and all assessments in Italian and English here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.